Aminostigmine

Aminostigmine: description, application and manufacturers

Aminostigmine (international name - Amynostigmine) is a drug belonging to the group of cholinesterase inhibitors. It is used to treat myasthenia gravis, a disease characterized by weakening muscle strength. Aminostigmine helps increase the amount of acetylcholine, a substance that transmits impulses from nerves to muscles, which increases muscle strength and reduces weakness.

Aminostigmine is produced in Russia, in particular, by the companies Biomed and GNIISKLS. Dosage form of Aminostigmine - substance and solution for injection 0.1%.

Aminostigmine is an effective treatment for myasthenia gravis and can be prescribed by a doctor depending on the patient's condition. However, like any other drug, Aminostigmine has contraindications and side effects.

Contraindications include an allergic reaction to the drug, bronchial asthma, angina pectoris, hypertension, gastric and duodenal ulcers, as well as pregnancy and breastfeeding. Side effects may include headache, nausea, vomiting, diarrhea, sweating, weakness, heart rhythm disturbances, etc.

It is important to remember that medications should only be taken as prescribed by a doctor and in accordance with the recommended doses. If you experience any unpleasant symptoms while taking Aminostigmine, you should contact your doctor immediately.

Thus, Aminostigmine is an effective drug for the treatment of myasthenia gravis, which is produced in Russia by Biomed and GNIISKLS. But it is necessary to remember that the drug should be taken only as prescribed by a doctor and under his supervision.